This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Aicuris Gmbh + Co. Kg., Aic246 Ag & Co. Kg. Active years: 2016-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2024
Title: Welljanne Maertens: Innovator in Antiviral Drug Development
Introduction
Welljanne Maertens is a notable inventor based in Dresden, Germany. He has made significant contributions to the field of antiviral drug development, holding a total of three patents. His work focuses on innovative solutions for treating and preventing viral infections.
Latest Patents
Maertens' latest patents include the invention of salts of a dihydroquinazoline derivative. This invention relates to besylate and tosylate salts of a specific compound, which is used in methods for treating and preventing virus infections. The compounds are particularly aimed at developing drugs that serve as antiviral agents, especially against cytomegaloviruses.
Career Highlights
Throughout his career, Welljanne Maertens has worked with prominent companies in the pharmaceutical sector. Notably, he has been associated with Aicuris GmbH & Co. KG and Aic246 AG & Co. KG. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
[This section has been skipped due to space constraints.]
Conclusion
Welljanne Maertens is a distinguished inventor whose work in antiviral drug development has the potential to impact public health significantly. His innovative patents and career achievements reflect his dedication to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile